Shuffle for fans
Chatbot

BioTech IQ

Science • Business

Increase your IQ and understanding of the Biotech industry by listening to interviews with key business leaders who have built successful companies and departments. We discuss everything from the science, clinical operations, clinical development, safety/PV and more! We address how each functionRead more

Popular episodes

#31 Managing CRO relationships and unique business models - Stewart Hallet - COO SFJ Pharmaceuticals

Nov 24 • 01:04:19

#30 Brazen Bio Part II - Live and In Person!

Nov 4 • 40:13

Co-founders Shawn Carbonell and Brent Witgen discuss the progress of the 1st cohort (BRZ1) as they are well into the Brazen Bio program. We also get the chance to interview one of the founders currently in the program. We discuss what he is working on and what his experience has been in the program. Do you have a project that needs acceleration? Then don't hesitate, go to

#29 Why do we resist? Applying clinical psychology to clinical trials. Kathleen Starr, PhD - EVP Behavioral Insights, Syneos Health

Oct 29 • 57:48

Kathleen shares fantastic insights on understanding behavioral psychology and how it applies to successful clinical trials. We had a great conversation that touched on increasing diversity in trials to understanding our own behavior and how we can potentially understand patients better. This can be applied in a way to close the gap between intention and action. Kathleen co...

#28 Vaccine Durability, Diversified Pipeline, Winning Strategy - Seth Lederman, MD - CEO Tonix Pharmaceuticals

Oct 1 • 56:19

Seth Lederman is the CEO of Tonix Pharmaceuticals and a physician scientist with a two decades of research experience. Prior to becoming an entrepreneur, he was an Associate Professor at Columbia University. Dr. Lederman’s groundbreaking research led to the discovery of the CD-40 ligand and its role in T cell helper function. Currently, Dr. Lederman oversees Tonix Pharmace...

#27 How do you effectively manage the CMC process? With Doug Looker, PhD

Sep 21 • 29:21

Doug Looker is the VP of Operations with Validus Cellular Therapeutics. Validus is using cellular therapy to target infections by fighting the biology of antimicrobial resistance by activating the biology of the mammalian immune system. Doug walks us the through the process of establishing the CMC process that will drive success at every stage of the clinical trial process...

#26 How do you know the right path of development? Mike Rea, CEO - IDEA Pharma

Sep 1 • 54:40

Mike is the CEO of IDEA Pharma and author of the Pharmaceutical Innovation Index. He just launched a new company, Protodigm, that’s mission is to act as a pharma/biotech skunkworks that can test and troubleshoot drug development and avoid failure by determining the best possible development paths. Here’s the release. ...

#25 Potential Tumor Immunity? Grant Yonehiro, CBO - Bolt BioTherapeutics

Aug 11 • 52:21

Grant is the Chief Business Officer with Bolt BioTherapeutics. Bolt Bio recently went public in February this year and announced a partnership with Genmab. Grant talks business development strategy and helping to navigate Bolt through their recent milestones.

Bolt Bio focuses on the development of ISACs – immune-stimulating antibody conjugates – which are anti-cancer drugs ...

#24 A fellowship program for biotech founders? Meet: Brazen Bio

Jul 16 • 38:08

The founders of Brazen Bio discuss how their program is helping potential biotech founders prove their concepts and launch their company. Be Brazen!

Shawn Carbonell, MD, PhD quit his neurosurgery residency to found his first biotech startup a decade ago. He had invented and developed a first-in-class cancer drug which is currently in phase 1 clinical trial....

#23 Targeting treatment related toxicities - Michael McCullar - CEO OnQuality Pharmaceuticals

Jul 9 • 47:25

#22 Regulatory Affairs Strategy w/Dr. Jethro Ekuta - VP, Global RA

Jun 25 • 59:28

Dr. Ekuta helps to educate us on the function of regulatory affairs by sharing an acronym he calls RCI. Regulatory Requirements, Compliance, and Interaction. He shares how regulatory affairs professionals can had value to companies at all stages of the process, pre-clinical to post-market. Dr. Ekuta is currently the VP of Global Regulatory Affairs with Alexion Pharmaceutic...

Check out similar podcasts

Pauly Shore's Random Rants
All Things Comedy
Finance Forward – der Podcast für die neue Finanzwelt
Niklas Wirminghaus und Caspar Schlenk | Finance FWD
Wacky Leaks
Guerrilla Podcast Syndicate Philippines
TwitterBlogCareersPress KitCommunity GuidelinesTerms of ServicePrivacy Policy
© 2021 Akora Labs, Inc.